Grants and Contributions:
Title:
PRescribing Outcomes Modeled through Intelligent Systems Engineering (PROMISE)
Agreement Number:
977782
Agreement Value:
$212,000.00
Agreement Date:
Sep 1, 2021 - Aug 31, 2022
Description:
Develop and test a machine learning model to predict the 30-day risk of hospitalization, emergency department visit (ED), or death after a person in Alberta receives an opioid or benzodiazepine prescription and develop/validate an end-to-end platform to simulate the use of this ML model as part of Alberta's prescription monitoring program for controlled drugs (Alberta TPP).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2L 2K7
Reference Number:
172-2021-2022-Q2-977782
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
800653354
Recipient Type:
For-profit organization
Recipient's Legal Name:
Okaki Health Intelligence Inc.
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211